Join us for a moderated panel discussion ahead of the 2021 ASH Annual Meeting & Exposition, which will focus on malignant and non-malignant hematology. The webinar will include an introduction to key themes included in a recent IQVIA Institute report on Global Oncology Trends 2021 as well as the following themes:

• Expectations around ASH 2021
• The impact of COVID-19 on hematology/oncology research and care
• Clinical trial endpoints in hematology/oncology
• Randomized clinical trials and real-world evidence

Confirmed speakers to-date:

• Asif Alavi, MD, Physician, Oncology and Hematology, Karmanos Cancer Institute
• Jorge Cortes, MD, Director, Georgia Cancer Center, Augusta University
• Terry Fry, MD, Head of T Cell Therapeutics, Sana Biotechnology
• Oliver Ottmann, MD, Professor and Head of Haematology, Division of Cancer and Genetics, Cardiff University
• JJ Strouse, MD, Ph.D., Associate Professor of Medicine, Duke University

Moderator:

Jeff Keefer, MD, Ph.D., VP and Global Head, Oncology Center of Excellence, IQVIA